Advertisement

Inflammation

, Volume 42, Issue 1, pp 20–34 | Cite as

Induced Expression of Endogenous CXCR4 in iPSCs by Targeted CpG Demethylation Enhances Cell Migration Toward the Ligand CXCL12

  • Can Jiang
  • Jun GuoEmail author
  • Huaiyan Cheng
  • Ying-Hong Feng
ORIGINAL ARTICLE

Abstract

Poor homing of cells after transplantation is an unresolved common issue in cardiac cell therapies. To enhance stem cell homing, the ligand CXC motif chemokine 12 (CXCL12) and its specific receptor CXC receptor type 4 (CXCR4) have been employed as a system in this study to show that induced expression of the endogenous CXCR4 gene in mouse-induced pluripotent stem cells (iPSCs) improved the cell migration. Loci-specific epigenome editing in the form of CpG demethylation at CXCR4 promoter region of the mouse iPSCs was accomplished with CXCR4b-TAL-Tet1c, chimeric fusion proteins of the catalytic domain of ten-eleven translocation 1 (TET1) to the C-terminal end of the DNA binding domains of predesigned synthetic transcription activator-like effectors (TALEs) that recognize specific DNA sequences within the mouse CXCR4 promoter region. Infection of the mouse iPSCs with the engineered CXCR4b-TAL-Tet1c in the form of lentiviral particles induced the loci-specific CpG demethylation and subsequent activation of CXCR4 expression in mouse iPSCs. As expected, the CXCR4-overexpressing iPSCs exhibited 3.9-fold greater migration than the control iPSCs did without alteration of the stemness and activated phosphorylation of AKT significantly. These results set a sound foundation for subsequent in vivo iPSCs transplantation studies in rodent models of acute myocardial infarction and heart failure. We show that TALEs can enhance the expression of CXCR4 by CpG methylation, and may retain the stemness. Migration of iPSCs activated by CXCL12 is associated with significant phosphorylation of AKT, not ERK1/2.

KEY WORDS

IPSCs (induced pluripotent stem cells) TALEs (transcription activator-like effectors) CXCR4 CpG methylation epigenome editing 

Notes

Authors’ Contributions

CJ conducted the most of the experiments and wrote the paper. JG conceived the idea for the paper, conducted experiments of real-time PCR and cell viability, and wrote the paper with CJ; and HYC conducted experiments on the CXCR4 reporter construction and in vitro CpG methylation. YHF revised the paper critically for important intellectual content, analyzed the experiments of Figs. 1 and 2, final approvaled of the version to be published.

Funding

This work was supported in part by the National Natural Science Foundation of China [81673635 and 81100078], Scientific research project of Guangdong Provincial Administration of traditional Chinese Medicine [20171072], and Science Research Foundation of Jinan university [21615478].

Compliance with Ethical Standards

Competing Interests

The authors declare that they have no competing interests.

Supplementary material

10753_2018_869_MOESM1_ESM.pdf (163 kb)
Fig. S1 (PDF 163 kb)
10753_2018_869_MOESM2_ESM.pdf (243 kb)
Fig. S2 (PDF 242 kb)

References

  1. 1.
    Lunde, K., and S. Aakhus. 2008. Cell therapy in acute myocardial infarction: measures of efficacy. Heart 94: 969–970.CrossRefGoogle Scholar
  2. 2.
    Yang, L., M.H. Soonpaa, E.D. Adler, T.K. Roepke, S.J. Kattman, M. Kennedy, E. Henckaerts, K. Bonham, G.W. Abbott, R.M. Linden, L.J. Field, and G.M. Keller. 2008. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453: 524–528.CrossRefGoogle Scholar
  3. 3.
    Martins, A.M., G. Vunjak-Novakovic, and R.L. Reis. 2014. The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine. Stem Cell Reviews 10: 177–190.CrossRefGoogle Scholar
  4. 4.
    Gersbach, C.A., T. Gaj, and C.F. Barbas III. 2014. Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies. Accounts of Chemical Research 47: 2309–2318.CrossRefGoogle Scholar
  5. 5.
    Sander, J.D., and J.K. Joung. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nature Biotechnology 32: 347–355.CrossRefGoogle Scholar
  6. 6.
    Reyon, D., S.Q. Tsai, C. Khayter, J.A. Foden, J.D. Sander, and J.K. Joung. 2012. FLASH assembly of TALENs for high-throughput genome editing. Nature Biotechnology 30: 460–465.CrossRefGoogle Scholar
  7. 7.
    Pattanayak, V., S. Lin, J.P. Guilinger, E. Ma, J.A. Doudna, and D.R. Liu. 2013. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nature Biotechnology 31: 839–843.CrossRefGoogle Scholar
  8. 8.
    Ebina, H., Y. Kanemura, N. Misawa, T. Sakuma, T. Kobayashi, T. Yamamoto, and Y. Koyanagi. 2015. A high excision potential of TALENs for integrated DNA of HIV-based lentiviral vector. PLoS One 10: e0120047.CrossRefGoogle Scholar
  9. 9.
    Mussolino, C., R. Morbitzer, F. Lutge, N. Dannemann, T. Lahaye, and T. Cathomen. 2011. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Research 39: 9283–9293.CrossRefGoogle Scholar
  10. 10.
    Maeder, M.L., J.F. Angstman, M.E. Richardson, S.J. Linder, V.M. Cascio, S.Q. Tsai, Q.H. Ho, J.D. Sander, D. Reyon, B.E. Bernstein, J.F. Costello, M.F. Wilkinson, and J.K. Joung. 2013. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nature Biotechnology 31: 1137–1142.CrossRefGoogle Scholar
  11. 11.
    Li, K., J. Pang, H.Y. Cheng, W.P. Liu, J.M. Di, H.J. Xiao, Y. Luo, H. Zhang, W.T. Huang, M.K. Chen, L.Y. Li, C.K. Shao, Y.H. Feng, and X. Gao. 2015. Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase. Oncotarget 6: 10030–10044.Google Scholar
  12. 12.
    Cencioni, C., M.C. Capogrossi, and M. Napolitano. 2012. The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovascular Research 94: 400–407.CrossRefGoogle Scholar
  13. 13.
    Wu, Y., and R.C. Zhao. 2012. The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Reviews 8: 243–250.CrossRefGoogle Scholar
  14. 14.
    Tang, Y.L., W. Zhu, M. Cheng, L. Chen, J. Zhang, T. Sun, R. Kishore, M.I. Phillips, D.W. Losordo, and G. Qin. 2009. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circulation Research 104: 1209–1216.CrossRefGoogle Scholar
  15. 15.
    Askari, A.T., S. Unzek, Z.B. Popovic, C.K. Goldman, F. Forudi, M. Kiedrowski, A. Rovner, S.G. Ellis, J.D. Thomas, P.E. DiCorleto, E.J. Topol, and M.S. Penn. 2003. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697–703.CrossRefGoogle Scholar
  16. 16.
    Jiang, J., W. Lv, X. Ye, L. Wang, M. Zhang, H. Yang, M. Okuka, C. Zhou, X. Zhang, L. Liu, and J. Li. 2013. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation. Cell Research 23 (1): 92–106.CrossRefGoogle Scholar
  17. 17.
    Yamanaka, S. 2007. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1: 39–49.CrossRefGoogle Scholar
  18. 18.
    Song, G., X. Li, Y. Shen, L. Qian, X. Kong, M. Chen, K. Cao, and F. Zhang. 2015. Transplantation of iPSc restores cardiac function by promoting angiogenesis and ameliorating cardiac remodeling in a post-infarcted swine model. Cell Biochemistry and Biophysics 71: 1463–1473.CrossRefGoogle Scholar
  19. 19.
    Menasche, P. 2004. Cellular transplantation: hurdles remaining before widespread clinical use. Current Opinion in Cardiology 19: 154–161.CrossRefGoogle Scholar
  20. 20.
    Pillarisetti, K., and S.K. Gupta. 2001. Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)(1): SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation 25: 293–300.CrossRefGoogle Scholar
  21. 21.
    Takahashi, M. 2010. Role of the SDF-1/CXCR4 system in myocardial infarction. Circulation Journal 74: 418–423.CrossRefGoogle Scholar
  22. 22.
    Hu, X., S. Dai, W.J. Wu, W. Tan, X. Zhu, J. Mu, Y. Guo, R. Bolli, and G. Rokosh. 2007. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116: 654–663.CrossRefGoogle Scholar
  23. 23.
    Yu, J., M.C. Li, Z.L. Qu, D. Yan, D. Li, and Q.R. Ruan. 2010. SDF-1/CXCR4-mediated migration of transplanted bone marrow stromal cells toward areas of heart myocardial infarction through activation of PI3K/Akt. Journal of Cardiovascular Pharmacology 55: 496–505.Google Scholar
  24. 24.
    Tilokee, E.L., N. Latham, R. Jackson, A.E. Mayfield, B. Ye, S. Mount, B.K. Lam, E.J. Suuronen, M. Ruel, D.J. Stewart, and D.R. Davis. 2016. Paracrine engineering of human explant-derived cardiac stem cells to over-express stromal-cell derived factor 1alpha enhances myocardial repair. Stem Cells 34: 1826–1835.CrossRefGoogle Scholar
  25. 25.
    Hadad, I. 2013. Stroma cell-derived Factor-1 alpha signaling enhances calcium transients and beating frequency in rat neonatal cardiomyocytes. PLoS One 8: e56007.CrossRefGoogle Scholar
  26. 26.
    Suzuki, M.M., and A. Bird. 2008. DNA methylation landscapes: provocative insights from epigenomics. Nature Reviews. Genetics 9: 465–476.CrossRefGoogle Scholar
  27. 27.
    Deng, D., P. Yin, C. Yan, X. Pan, X. Gong, S. Qi, T. Xie, M. Mahfouz, J.K. Zhu, N. Yan, and Y. Shi. 2012. Recognition of methylated DNA by TAL effectors. Cell Research 22: 1502–1504.CrossRefGoogle Scholar
  28. 28.
    Tang, Z., W.Y. Chen, M. Shimada, Kim J. Nquyen, X.J. Sun, T. Senqoku, R.K. McGinty, J.P. Fernandez, T.W. Muir, and R.G. Roeder. 2013. SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell 154: 297–310.CrossRefGoogle Scholar
  29. 29.
    Delgado-Martin, C., C. Escribano, J.L. Pablos, L. Riol-Blanco, and J.L. Rodriguez-Fernandez. 2011. Chemokine CXCL12 uses CXCR4 and a signaling core formed by bifunctional Akt, extracellular signal-regulated kinase (ERK)1/2, and mammalian target of rapamycin complex 1 (mTORC1) proteins to control chemotaxis and survival simultaneously in mature dendritic cells. The Journal of Biological Chemistry 286: 37222–37236.CrossRefGoogle Scholar
  30. 30.
    Yang, F., W. Sun, Y. Yang, C.L. Li, H. Fu, X.L. Wang, F. Yang, T. He, and J. Chen. 2015. SDF1-CXCR4 signaling contributes to persistent pain and hypersensitivity via regulating excitability of primary nociceptive neurons: involvement of ERK-dependent Nav1.8 up-regulation. Journal of Neuroinflammation 12: 219.CrossRefGoogle Scholar
  31. 31.
    Ryu, C.H., S.A. Park, S.M. Kim, J.Y. Lim, C.H. Jeong, J.A. Jun, J.H. Oh, S.H. Park, W.I. Oh, and S.S. Jeun. 2010. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochemical and Biophysical Research Communications 398: 105–110.CrossRefGoogle Scholar
  32. 32.
    Zilkha-Falb, R., N. Kaushansky, N. Kawakami, and A. Ben-Nun. 2016. Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease. Journal of Neuroinflammation 13: 7.CrossRefGoogle Scholar
  33. 33.
    Zou, Y.R., A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595–599.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Can Jiang
    • 1
  • Jun Guo
    • 1
    Email author
  • Huaiyan Cheng
    • 2
  • Ying-Hong Feng
    • 2
  1. 1.Department of CardiologyThe First Affiliated Hospital of Jinan UniversityGuangzhouPeople’s Republic of China
  2. 2.Department of Pharmacology & Molecular TherapeuticsUniformed Services University of the Health SciencesBethesdaUSA

Personalised recommendations